Leerink Partners Maintains Bullish View on GW Pharma (GWPH) Posts Q2
Tweet Send to a Friend
Leerink Partners analyst Paul Matteis reiterated an Outperform rating and $135 price target on GW Pharma (NASDAQ: GWPH) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
